IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1167/iovs.08-2158 on December 20, 2008
(Investigative Ophthalmology and Visual Science. 2009;50:4934-4940.)
© 2009 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.08-2158

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.08-2158v1
50/10/4934    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Google Scholar
Right arrow Articles by Bartoli, M.
Right arrow Articles by Caldwell, R. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartoli, M.
Right arrow Articles by Caldwell, R. B.

HMG-CoA Reductase Inhibitors (Statin) Prevents Retinal Neovascularization in a Model of Oxygen-Induced Retinopathy

Manuela Bartoli,2,3 Mohamed Al-Shabrawey,4 Mohamed Labazi,5 M. Ali Behzadian,5 Mohamed Istanboli,5 Azza B. El-Remessy,6 Robert W. Caldwell,7 Dennis M. Marcus,2 and Ruth B. Caldwell1,5

1From the VA Medical Center, Augusta, Georgia; the 2Department of Ophthalmology, University of South Carolina School of Medicine, Columbia, South Carolina; 3Fondazione GB Bietti IRCCS, Onlus, Rome, Italy; the 4Departments of Oral Biology and Anatomy, School of Dentistry, 5Cellular Biology and Anatomy, Vascular Biology Center, and 7Pharmacology and Toxicology, Medical College of Georgia, Augusta, Georgia; and the 6College of Pharmacy, University of Georgia, Augusta, Georgia.

PURPOSE. Retinal neovascularization (RNV) is a primary cause of blindness and involves the dysfunction of retinal capillaries. Recent studies have emphasized the beneficial effects of inhibitors of HMG-CoA reductase (statins) in preventing vascular dysfunction. In the present study, the authors characterized the therapeutic effects of statins on RNV.

METHODS. Statin treatment (10 mg/kg/d fluvastatin) was tested in a mouse model of oxygen-induced retinopathy. Morphometric analysis was conducted to determine the extent of capillary growth. Pimonidazole hydrochloride was used to assess retinal ischemia. Western blot and immunohistochemical analyses were used to assess protein expression levels and immunolocalization. Lipid peroxidation and superoxide radical formation were determined to assess oxidative changes.

RESULTS. Fluvastatin treatment significantly reduced the area of the capillary-free zone (P < 0.01), decreased the formation of neovascular tufts (P < 0.01), and ameliorated retinal ischemia. These morphologic and functional changes were associated with statin effects in preventing the upregulation of VEGF, HIF-1{alpha}, phosphorylated STAT3, and vascular expression of the inflammatory mediator ICAM-1 (P < 0.01). Superoxide production and lipid peroxidation in the ischemic retina were also reduced by statin treatment (P < 0.01).

CONCLUSIONS. These data suggest the beneficial effects of statin treatment in preventing retinal neovascularization. These beneficial effects appear to result from the anti-oxidant and anti-inflammatory properties of statins.





This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. Abdelsaid, B. A. Pillai, S. Matragoon, R. Prakash, M. Al-Shabrawey, and A. B. El-Remessy
Early Intervention of Tyrosine Nitration Prevents Vaso-Obliteration and Neovascularization in Ischemic Retinopathy
J. Pharmacol. Exp. Ther., January 1, 2010; 332(1): 125 - 134.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Association for Research in Vision and Ophthalmology